Allergan, Inc. (AGN) Misses Q4 EPS by 5c; Issues Mixed FY13 Outlook
Tweet Send to a Friend
Allergan, Inc. (NYSE: AGN) reported Q4 EPS of $1.15, $0.05 worse than the analyst estimate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
